FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765931561> ?p ?o ?g. }

• W2765931561 endingPage "294" @default.
• W2765931561 startingPage "276" @default.
• W2765931561 abstract "Abstract Purpose: As previously reported, treatment of high-grade cervical dysplasia with VGX-3100 resulted in complete histopathologic regression (CR) concomitant with elimination of HPV16/18 infection in 40.0% of VGX-3100–treated patients compared with only 14.3% in placebo recipients in a randomized phase IIb study. Here, we identify clinical and immunologic characteristics that either predicted or correlated with therapeutic benefit from VGX-3100 to identify parameters that might guide clinical decision-making for this disease. Experimental Design: We analyzed samples taken from cervical swabs, whole blood, and tissue biopsies/resections to determine correlates and predictors of treatment success. Results: At study entry, the presence of preexisting immunosuppressive factors such as FoxP3 and PD-L1 in cervical lesions showed no association with treatment outcome. The combination of HPV typing and cervical cytology following dosing was predictive for both histologic regression and elimination of detectable virus at the efficacy assessment 22 weeks later (negative predictive value 94%). Patients treated with VGX-3100 who had lesion regression had a statistically significant &gt;2-fold increase in CD137+perforin+CD8+ T cells specific for the HPV genotype causing disease. Increases in cervical mucosal CD137+ and CD103+ infiltrates were observed only in treated patients. Perforin+ cell infiltrates were significantly increased &gt;2-fold in cervical tissue only in treated patients who had histologic CR. Conclusions: Quantitative measures associated with an effector immune response to VGX-3100 antigens were associated with lesion regression. Consequently, these analyses indicate that certain immunologic responses associate with successful resolution of HPV-induced premalignancy, with particular emphasis on the upregulation of perforin in the immunotherapy-induced immune response. Clin Cancer Res; 24(2); 276–94. ©2017 AACR." @default.
• W2765931561 created "2017-11-10" @default.
• W2765931561 creator A5012244788 @default.
• W2765931561 creator A5014787955 @default.
• W2765931561 creator A5015488396 @default.
• W2765931561 creator A5023265367 @default.
• W2765931561 creator A5025867351 @default.
• W2765931561 creator A5034146116 @default.
• W2765931561 creator A5041625714 @default.
• W2765931561 creator A5043851739 @default.
• W2765931561 creator A5045028558 @default.
• W2765931561 creator A5049047352 @default.
• W2765931561 creator A5053182799 @default.
• W2765931561 creator A5067843924 @default.
• W2765931561 creator A5071608389 @default.
• W2765931561 creator A5074185619 @default.
• W2765931561 creator A5075347801 @default.
• W2765931561 creator A5079512093 @default.
• W2765931561 date "2018-01-15" @default.
• W2765931561 modified "2023-10-03" @default.
• W2765931561 title "Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy" @default.
• W2765931561 cites W1251599274 @default.
• W2765931561 cites W1486308585 @default.
• W2765931561 cites W1506618532 @default.
• W2765931561 cites W1512799118 @default.
• W2765931561 cites W1632859538 @default.
• W2765931561 cites W1688526230 @default.
• W2765931561 cites W1752668680 @default.
• W2765931561 cites W1759105571 @default.
• W2765931561 cites W1855030145 @default.
• W2765931561 cites W190015672 @default.
• W2765931561 cites W1969504080 @default.
• W2765931561 cites W1985278235 @default.
• W2765931561 cites W1991260070 @default.
• W2765931561 cites W1991692524 @default.
• W2765931561 cites W2003579048 @default.
• W2765931561 cites W2012267998 @default.
• W2765931561 cites W2022228137 @default.
• W2765931561 cites W2053238499 @default.
• W2765931561 cites W2060786724 @default.
• W2765931561 cites W2064273388 @default.
• W2765931561 cites W2076027168 @default.
• W2765931561 cites W2105240629 @default.
• W2765931561 cites W2107415042 @default.
• W2765931561 cites W2114418380 @default.
• W2765931561 cites W2126910013 @default.
• W2765931561 cites W2128471759 @default.
• W2765931561 cites W2129727233 @default.
• W2765931561 cites W2131915942 @default.
• W2765931561 cites W2136268327 @default.
• W2765931561 cites W2144555377 @default.
• W2765931561 cites W2146197530 @default.
• W2765931561 cites W2155959680 @default.
• W2765931561 cites W2156383220 @default.
• W2765931561 cites W2157167593 @default.
• W2765931561 cites W2162681066 @default.
• W2765931561 cites W2164710273 @default.
• W2765931561 cites W2167755712 @default.
• W2765931561 cites W2170314746 @default.
• W2765931561 cites W2183385634 @default.
• W2765931561 cites W2184502146 @default.
• W2765931561 cites W2342029300 @default.
• W2765931561 cites W2345307430 @default.
• W2765931561 cites W2461102849 @default.
• W2765931561 cites W2516494390 @default.
• W2765931561 cites W2521930878 @default.
• W2765931561 cites W4238423864 @default.
• W2765931561 doi "https://doi.org/10.1158/1078-0432.ccr-17-2335" @default.
• W2765931561 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6956401" @default.
• W2765931561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29084917" @default.
• W2765931561 hasPublicationYear "2018" @default.
• W2765931561 type Work @default.
• W2765931561 sameAs 2765931561 @default.
• W2765931561 citedByCount "32" @default.
• W2765931561 countsByYear W27659315612018 @default.
• W2765931561 countsByYear W27659315612019 @default.
• W2765931561 countsByYear W27659315612020 @default.
• W2765931561 countsByYear W27659315612021 @default.
• W2765931561 countsByYear W27659315612022 @default.
• W2765931561 countsByYear W27659315612023 @default.
• W2765931561 crossrefType "journal-article" @default.
• W2765931561 hasAuthorship W2765931561A5012244788 @default.
• W2765931561 hasAuthorship W2765931561A5014787955 @default.
• W2765931561 hasAuthorship W2765931561A5015488396 @default.
• W2765931561 hasAuthorship W2765931561A5023265367 @default.
• W2765931561 hasAuthorship W2765931561A5025867351 @default.
• W2765931561 hasAuthorship W2765931561A5034146116 @default.
• W2765931561 hasAuthorship W2765931561A5041625714 @default.
• W2765931561 hasAuthorship W2765931561A5043851739 @default.
• W2765931561 hasAuthorship W2765931561A5045028558 @default.
• W2765931561 hasAuthorship W2765931561A5049047352 @default.
• W2765931561 hasAuthorship W2765931561A5053182799 @default.
• W2765931561 hasAuthorship W2765931561A5067843924 @default.
• W2765931561 hasAuthorship W2765931561A5071608389 @default.
• W2765931561 hasAuthorship W2765931561A5074185619 @default.
• W2765931561 hasAuthorship W2765931561A5075347801 @default.
• W2765931561 hasAuthorship W2765931561A5079512093 @default.
• W2765931561 hasBestOaLocation W27659315611 @default.

• next